Form 4 Filing for GILL SIMBA

This filing details a Form 4 filed by GILL SIMBA, a director at Foghorn Therapeutics Inc. (FHTX). On June 24, 2026, Simba was granted 28,000 stock options with a right to buy at a price of $4.08 per share. These options vest in full on the first anniversary of the grant date, contingent upon Simba's continued service on the board of directors. The underlying security for these options is Foghorn Therapeutics Inc. Common Stock. The transaction code indicates acquisition, and the post-transaction shares owned by Simba are 28,000. The filing was signed on June 25, 2026, by Michael LaCascia as Attorney-in-Fact for GILL SIMBA.